Use of the Gail Model and Breast Cancer Preventive Therapy among Three Primary Care Specialties

Jennifer Corbelli, Sonya Borrero, Rachel Bonnema, Megan McNamara, Kevin Kraemer, Doris Rubio, Irina Karpov, Melissa McNeil

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Breast cancer is an issue of serious concern among women of all ages. The extent to which providers across primary care specialties assess breast cancer risk and discuss chemoprevention is unknown. Methods: Cross-sectional web-based survey completed by 316 physicians in internal medicine (IM), family medicine (FM), and gynecology (GYN) from February to April of 2012. Survey items assessed respondents' frequency of use of the Gail model and chemoprevention, and their attitudes behind practice patterns. Descriptive statistics were used to generate response distributions, and chi-squared tests were used to compare responses among specialties. Results: The response rate was 55.0 % (316/575). Only 40% of providers report having used the Gail model (37% IM, 33% FM, 60% GYN) and 13% report having recommended or prescribed chemoprevention (9% IM, 8% FM, 30% GYN). Among providers who use the Gail model, a minority use it regularly in patients who may be at increased breast cancer risk. Among providers who have prescribed chemoprevention, most have done so five times or fewer. Lack of both time and familiarity were commonly cited barriers to use of the Gail score and chemoprevention. Conclusions: An overall minority of providers, most notably in FM and IM, use the Gail model to assess, and chemoprevention to decrease, breast cancer risk. Until providers are more consistent in their use of the Gail model (or other breast cancer risk calculator) and chemoprevention, opportunities to intervene in women at increased risk will likely continue to be missed.

Original languageEnglish (US)
Pages (from-to)746-752
Number of pages7
JournalJournal of Women's Health
Volume23
Issue number9
DOIs
StatePublished - Sep 1 2014

Fingerprint

Chemoprevention
Primary Health Care
Breast Neoplasms
Internal Medicine
Gynecology
Medicine
Therapeutics
Physicians
Surveys and Questionnaires

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Corbelli, J., Borrero, S., Bonnema, R., McNamara, M., Kraemer, K., Rubio, D., ... McNeil, M. (2014). Use of the Gail Model and Breast Cancer Preventive Therapy among Three Primary Care Specialties. Journal of Women's Health, 23(9), 746-752. https://doi.org/10.1089/jwh.2014.4742

Use of the Gail Model and Breast Cancer Preventive Therapy among Three Primary Care Specialties. / Corbelli, Jennifer; Borrero, Sonya; Bonnema, Rachel; McNamara, Megan; Kraemer, Kevin; Rubio, Doris; Karpov, Irina; McNeil, Melissa.

In: Journal of Women's Health, Vol. 23, No. 9, 01.09.2014, p. 746-752.

Research output: Contribution to journalArticle

Corbelli, J, Borrero, S, Bonnema, R, McNamara, M, Kraemer, K, Rubio, D, Karpov, I & McNeil, M 2014, 'Use of the Gail Model and Breast Cancer Preventive Therapy among Three Primary Care Specialties', Journal of Women's Health, vol. 23, no. 9, pp. 746-752. https://doi.org/10.1089/jwh.2014.4742
Corbelli, Jennifer ; Borrero, Sonya ; Bonnema, Rachel ; McNamara, Megan ; Kraemer, Kevin ; Rubio, Doris ; Karpov, Irina ; McNeil, Melissa. / Use of the Gail Model and Breast Cancer Preventive Therapy among Three Primary Care Specialties. In: Journal of Women's Health. 2014 ; Vol. 23, No. 9. pp. 746-752.
@article{2b8b0957f2514a2594dd53c059a1036e,
title = "Use of the Gail Model and Breast Cancer Preventive Therapy among Three Primary Care Specialties",
abstract = "Background: Breast cancer is an issue of serious concern among women of all ages. The extent to which providers across primary care specialties assess breast cancer risk and discuss chemoprevention is unknown. Methods: Cross-sectional web-based survey completed by 316 physicians in internal medicine (IM), family medicine (FM), and gynecology (GYN) from February to April of 2012. Survey items assessed respondents' frequency of use of the Gail model and chemoprevention, and their attitudes behind practice patterns. Descriptive statistics were used to generate response distributions, and chi-squared tests were used to compare responses among specialties. Results: The response rate was 55.0 {\%} (316/575). Only 40{\%} of providers report having used the Gail model (37{\%} IM, 33{\%} FM, 60{\%} GYN) and 13{\%} report having recommended or prescribed chemoprevention (9{\%} IM, 8{\%} FM, 30{\%} GYN). Among providers who use the Gail model, a minority use it regularly in patients who may be at increased breast cancer risk. Among providers who have prescribed chemoprevention, most have done so five times or fewer. Lack of both time and familiarity were commonly cited barriers to use of the Gail score and chemoprevention. Conclusions: An overall minority of providers, most notably in FM and IM, use the Gail model to assess, and chemoprevention to decrease, breast cancer risk. Until providers are more consistent in their use of the Gail model (or other breast cancer risk calculator) and chemoprevention, opportunities to intervene in women at increased risk will likely continue to be missed.",
author = "Jennifer Corbelli and Sonya Borrero and Rachel Bonnema and Megan McNamara and Kevin Kraemer and Doris Rubio and Irina Karpov and Melissa McNeil",
year = "2014",
month = "9",
day = "1",
doi = "10.1089/jwh.2014.4742",
language = "English (US)",
volume = "23",
pages = "746--752",
journal = "Journal of women's health (2002)",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "9",

}

TY - JOUR

T1 - Use of the Gail Model and Breast Cancer Preventive Therapy among Three Primary Care Specialties

AU - Corbelli, Jennifer

AU - Borrero, Sonya

AU - Bonnema, Rachel

AU - McNamara, Megan

AU - Kraemer, Kevin

AU - Rubio, Doris

AU - Karpov, Irina

AU - McNeil, Melissa

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Background: Breast cancer is an issue of serious concern among women of all ages. The extent to which providers across primary care specialties assess breast cancer risk and discuss chemoprevention is unknown. Methods: Cross-sectional web-based survey completed by 316 physicians in internal medicine (IM), family medicine (FM), and gynecology (GYN) from February to April of 2012. Survey items assessed respondents' frequency of use of the Gail model and chemoprevention, and their attitudes behind practice patterns. Descriptive statistics were used to generate response distributions, and chi-squared tests were used to compare responses among specialties. Results: The response rate was 55.0 % (316/575). Only 40% of providers report having used the Gail model (37% IM, 33% FM, 60% GYN) and 13% report having recommended or prescribed chemoprevention (9% IM, 8% FM, 30% GYN). Among providers who use the Gail model, a minority use it regularly in patients who may be at increased breast cancer risk. Among providers who have prescribed chemoprevention, most have done so five times or fewer. Lack of both time and familiarity were commonly cited barriers to use of the Gail score and chemoprevention. Conclusions: An overall minority of providers, most notably in FM and IM, use the Gail model to assess, and chemoprevention to decrease, breast cancer risk. Until providers are more consistent in their use of the Gail model (or other breast cancer risk calculator) and chemoprevention, opportunities to intervene in women at increased risk will likely continue to be missed.

AB - Background: Breast cancer is an issue of serious concern among women of all ages. The extent to which providers across primary care specialties assess breast cancer risk and discuss chemoprevention is unknown. Methods: Cross-sectional web-based survey completed by 316 physicians in internal medicine (IM), family medicine (FM), and gynecology (GYN) from February to April of 2012. Survey items assessed respondents' frequency of use of the Gail model and chemoprevention, and their attitudes behind practice patterns. Descriptive statistics were used to generate response distributions, and chi-squared tests were used to compare responses among specialties. Results: The response rate was 55.0 % (316/575). Only 40% of providers report having used the Gail model (37% IM, 33% FM, 60% GYN) and 13% report having recommended or prescribed chemoprevention (9% IM, 8% FM, 30% GYN). Among providers who use the Gail model, a minority use it regularly in patients who may be at increased breast cancer risk. Among providers who have prescribed chemoprevention, most have done so five times or fewer. Lack of both time and familiarity were commonly cited barriers to use of the Gail score and chemoprevention. Conclusions: An overall minority of providers, most notably in FM and IM, use the Gail model to assess, and chemoprevention to decrease, breast cancer risk. Until providers are more consistent in their use of the Gail model (or other breast cancer risk calculator) and chemoprevention, opportunities to intervene in women at increased risk will likely continue to be missed.

UR - http://www.scopus.com/inward/record.url?scp=84920819415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920819415&partnerID=8YFLogxK

U2 - 10.1089/jwh.2014.4742

DO - 10.1089/jwh.2014.4742

M3 - Article

C2 - 25115368

AN - SCOPUS:84920819415

VL - 23

SP - 746

EP - 752

JO - Journal of women's health (2002)

JF - Journal of women's health (2002)

SN - 1540-9996

IS - 9

ER -